Related Experiment Video
Updated: Apr 26, 2026
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Tumor heterogeneity has important consequences for personalized medicine in ovarian cancer
Ting Gui1, Dongyan Cao1, Jiaxin Yang1
1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Abstract:
Most patients with ovarian cancers relapse, and treatment failure has often been attributed to chemoresistance in tumor cells. Emerging evidence indicates that tumor heterogeneity may play an equally important role. Although the idea of tumor heterogeneity is not new, little attention has been focused on applying it to understand and control ovarian cancer progression. Recent advances in understanding its generation model, original basis, consequent problems, and derived therapies provide great potential for tumor heterogeneity to be a new insight in treatment of ovarian cancers.
Insights
Ovarian cancer relapse is common, often due to chemoresistance. Tumor heterogeneity, the diversity within tumors, is emerging as a critical factor influencing treatment failure and offering new therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Ovarian cancer frequently relapses, with treatment failure often linked to chemotherapy resistance in tumor cells.
- Tumor heterogeneity, a concept not new to cancer research, is increasingly recognized as a significant factor in ovarian cancer progression and treatment outcomes.
Purpose of the Study:
- To highlight the underappreciated role of tumor heterogeneity in ovarian cancer progression.
- To explore recent advances in understanding the mechanisms and implications of tumor heterogeneity.
- To propose tumor heterogeneity as a novel therapeutic target for ovarian cancer treatment.
Main Methods:
- Review of recent scientific literature on tumor heterogeneity in ovarian cancer.
- Analysis of the generation models and underlying basis of tumor heterogeneity.
- Evaluation of therapeutic strategies derived from understanding tumor heterogeneity.
Main Results:
- Tumor heterogeneity significantly contributes to ovarian cancer relapse and treatment failure, alongside chemoresistance.
- Advances in understanding tumor heterogeneity provide insights into its generation, basis, and consequences.
- New therapeutic approaches targeting tumor heterogeneity show promise for improving ovarian cancer treatment.
Conclusions:
- Tumor heterogeneity is a critical factor in ovarian cancer progression and treatment resistance.
- Further research into the mechanisms of tumor heterogeneity can unlock novel therapeutic strategies.
- Leveraging insights into tumor heterogeneity offers a promising new direction for treating ovarian cancer.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:07Tumor Progression
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:18Cancer
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell